Cyban announces the appointment of The Honourable Jaala Pulford to its Board of Directors
Melbourne, Australia: 6 March 2023 – Australian medtech company Cyban has today announced the appointment of The Honourable Jaala Pulford to its Board of Directors.
Jaala Pulford was elected to the Victorian Parliament in 2006 as Member for Western Victoria. Over the first two terms of the Andrews Government (2014-22), Jaala was the first woman to serve as Minister for Agriculture, and had ministerial responsibilities that included roads, the TAC, fishing and boating, small business, resources, employment and for innovation, medical research, and the digital economy. She also served as Deputy Leader of the Government in the upper house,
In her role as Minister for Innovation, Medical Research and the Digital Economy, Jaala secured both Moderna and BioNTech for Melbourne, cementing a local end-to-end mRNA vaccine capability, supply certainty, an R&D hub and significant research investment. As Agriculture Minister she oversaw the establishment of a medicinal cannabis industry. She also set Victoria on course to be Australia’s first gigabit state through the Connecting Vic program, a billion-dollar investment delivered in partnership with telecommunications providers.
“I am delighted to join the Cyban team at a truly exciting time and I look forward to supporting the company in its ambition to be the next global success story to evolve from Victoria’s world class Medtech ecosystem.” Mrs Pulford said.
“Jaala is a strategic thinker and respected leader who brings a unique perspective and a breadth of experience to our Board. Her passion for helping people and businesses to thrive in an economy undergoing fast-moving, and transformational change along with her extensive network across government, business, health, and innovation will be a powerful asset for our organisation”, Andrew Maxwell, Cyban Chairman said.
------------------------
About Cyban
Cyban is focused on advancing the way brain injuries are detected and managed. Cyban's patented technology offers clinicians a non-invasive, continuous and simple to use product to monitor brain oxygen and intracranial pressure enabling early detection and treatment of brain injuries, resulting in better patient outcomes. Find out more at www.cyban.com.au
For more information contact:
Leah Sneddon
Email: leah.sneddon@amhurst.com.au
Phone: +61 427061206